Allied Market Research

2025

Japan Orphan Drugs Market

Japan Orphan Drugs Market, by DISEASE TYPE (ONCOLOGIC DISEASES, METABOLIC DISEASES, HEMATOLOGIC AND IMMUNOLOGIC DISEASES, INFECTIOUS DISEASES, NEUROLOGIC DISEASES, OTHER RARE DISEASES) and, by INDICATION (NON-HODGKIN LYMPHOMA, ACUTE MYELOID LEUKEMIA, CYSTIC FIBROSIS, GLIOMA, PANCREATIC CANCER, OVARIAN CANCER, MULTIPLE MYELOMA, DUCHENNE MUSCULAR DYSTROPHY, GRAFT VS HOST DISEASE, RENAL CELL CARCINOMA, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

  • Oct 2025

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (30% Off) $3,690 $2,583
Business User License (30% Off) $5,820 $4,074
Enterprise License (30% Off) $9,870 $6,909
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  Japan Orphan Drugs Market Report Highlights

Aspects Details
icon_5
By DISEASE TYPE
  • ONCOLOGIC DISEASES
  • METABOLIC DISEASES
  • HEMATOLOGIC AND IMMUNOLOGIC DISEASES
  • INFECTIOUS DISEASES
  • NEUROLOGIC DISEASES
  • OTHER RARE DISEASES
icon_6
By INDICATION
  • NON-HODGKIN LYMPHOMA
  • ACUTE MYELOID LEUKEMIA
  • CYSTIC FIBROSIS
  • GLIOMA
  • PANCREATIC CANCER
  • OVARIAN CANCER
  • MULTIPLE MYELOMA
  • DUCHENNE MUSCULAR DYSTROPHY
  • GRAFT VS HOST DISEASE
  • RENAL CELL CARCINOMA
  • Others
icon_7
Key Market Players

Kyowa Hakko Kirin Co., Ltd., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Daiichi Sankyo Company, Limited, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., Shionogi & Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Merck KGaA

Loading Table Of Content...

*Terms and Conditions Apply

Japan Orphan Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com